It confirmed that the molecule is metabolically stable, the half-life is optimal for weekly dosing, and the safety profile is comparable to GLP-1 agonists despite the glucagon component
Li Y, Ma QG, Zhao LH, Guo YQ, Duan GX, Zhang JY, Ji C (2014) Protective efficacy of alpha-lipoic acid against aflatoxinB1-induced oxidative damage in the liver
Cottone: We do believe these drugs may have the potential to be useful in a wide range of addictive disorders
234 Benfotiamine may improve neuropathic symptoms by reducing UDP-GlcNAc production
doi:10.1016/j.cmet.2018.02.011 Yoshino M, Yoshino J, Kayser BD, et al
In clinical trials, Trulicity 1.5mg produced average weight loss of approximately 6 lbs (2.7 kg) over 26 weeks